CHECK CAP LTD (CHEK) Stock Price & Overview
NASDAQ:CHEK • IL0011336851
The current stock price of CHEK is 1.61 USD. Today CHEK is up by 1.9%. In the past month the price increased by 11.03%. In the past year, price increased by 99.98%.
CHEK Key Statistics
- Market Cap
- 11.302M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -4.30
- Dividend Yield
- N/A
CHEK Stock Performance
CHEK Stock Chart
CHEK Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to CHEK. When comparing the yearly performance of all stocks, CHEK is one of the better performing stocks in the market, outperforming 97.33% of all stocks.
CHEK Earnings
CHEK Forecast & Estimates
CHEK Groups
Sector & Classification
CHEK Financial Highlights
Over the last trailing twelve months CHEK reported a non-GAAP Earnings per Share(EPS) of -4.3. The EPS decreased by -40.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6670.82% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
CHEK Ownership
CHEK Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.83 | 187.913B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.89 | 170.203B | ||
| SYK | STRYKER CORP | 22.3 | 129.047B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.6 | 101.721B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.46 | 49.099B | ||
| IDXX | IDEXX LABORATORIES INC | 38.53 | 45.48B | ||
| BDX | BECTON DICKINSON AND CO | 11.71 | 45.453B | ||
| RMD | RESMED INC | 18.93 | 33.857B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.053B | ||
| DXCM | DEXCOM INC | 25.67 | 25.116B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.92 | 18.115B | ||
| HOLX | HOLOGIC INC | 15.32 | 16.79B | ||
| PODD | INSULET CORP | 36.52 | 16.619B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CHEK
Company Profile
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
Company Info
IPO: 2015-02-19
CHECK CAP LTD
29 Abba Hushi Ave., P.O.Box 1271, Isfiya
Isfiya 3009000 IL
CEO: Alex Ovadia
Employees: 85
Phone: 97248303401
CHECK CAP LTD / CHEK FAQ
Can you describe the business of CHECK CAP LTD?
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
What is the stock price of CHECK CAP LTD today?
The current stock price of CHEK is 1.61 USD. The price increased by 1.9% in the last trading session.
Does CHECK CAP LTD pay dividends?
CHEK does not pay a dividend.
How is the ChartMill rating for CHECK CAP LTD?
CHEK has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the employee count for CHEK stock?
CHECK CAP LTD (CHEK) currently has 85 employees.
Who owns CHECK CAP LTD?
You can find the ownership structure of CHECK CAP LTD (CHEK) on the Ownership tab.